<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03181854</url>
  </required_header>
  <id_info>
    <org_study_id>HC15C1391-1</org_study_id>
    <nct_id>NCT03181854</nct_id>
  </id_info>
  <brief_title>Randomized Controlled Trial of Integrated Early Palliative Care</brief_title>
  <official_title>Randomized Controlled Trial of Integrated Early Palliative Care for Advanced Cancer Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Evidence-Based Healthcare Collaborating Agency</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Health, Korea</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Clinical Research Coordination Center, Seoul, Korea</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Severance Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Gyeongsang National University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chungnam National University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chonbuk National University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Daegu Fatima Hospital, South Korea</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hallym University Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Korea University Guro Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Asan Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chonnam National University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ewha Womans University Mokdong Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Keimyung University Dongsan Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ulsan University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pohang Semyeong Christianity Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Gangneung Asan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study verifies whether integrated Early Palliative Care for advanced cancer patients
      diagnosed due to a solid tumor improve quality of life and enhances the ability to overcome
      the current crisis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Previous reports suggest that starting palliative care early in cancer patients appears to
      improve patient's quality of life, symptom management, depression, and anxiety.

      This study aims to evaluate the effect of the introduction of early palliative care services
      to advanced cancer patients. Eligible patients are 20 years or older, and has an advanced
      cancer diagnosis (histologically or cytologically confirmed) due to a solid tumor, a European
      Cooperative Oncology Group performance status of 0-2, an estimated life expectancy of 12
      months or less. The primary goal of an integrated early palliative care program is to improve
      the overall quality of life of patients and their families. Secondarily, it is to help
      understand the disease, resolving conflicts in the decision-making process, improving the
      crisis coping capacity, and further determining the patient's and family's advanced care
      planning. At last, it is desired to evaluate the effect of the program on overall medical
      cost savings and 1 year survival.

      Participants of the study will be allocated in the intervention group and the control group
      equally. Within three weeks from the time of randomization, the first meeting with a
      palliative care team will be held. In the time of baseline questionnaire, patients will be
      provided with self-study education materials and videos on the early palliative care and
      advance care planning. Once in every three weeks for six months, which is the duration for
      one treatment course, palliative care for advance care planning, symptom control, and other
      mental, social and spiritual problems will be provided. After the first meeting with the
      palliative care team, telephone coaching will be performed once a week for the first 12 weeks
      and then every two weeks until the end of the study.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 8, 2017</start_date>
  <completion_date type="Anticipated">June 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in level of EORTC QLQ-C15-PAL</measure>
    <time_frame>baseline, 12 weeks</time_frame>
    <description>A questionnaire developed to assess the quality of life of palliative cancer care patients.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in level of MQOL</measure>
    <time_frame>Baseline, 12 weeks, 18 weeks, 24 weeks</time_frame>
    <description>A questionnaire that measures psychological, existential well-being, and support.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in level of EQ-5D of EuroQoL</measure>
    <time_frame>Baseline, 12 weeks, 18 weeks, 24 weeks</time_frame>
    <description>A questionnaire that measures mobility, self-care, daily activity, pain/discomfort, and anxiety/depression.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in level of PHQ-9</measure>
    <time_frame>Baseline, 12 weeks, 18 weeks, 24 weeks</time_frame>
    <description>9-question instrument given to patients in a primary care setting to screen for the presence and severity of depression.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in level of Understanding the illness</measure>
    <time_frame>Baseline, 12 weeks, 18 weeks, 24 weeks</time_frame>
    <description>2 questions to assess how patients understand the prognosis of their illness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in level of Crisis Overcoming Capability(SAT-SF)</measure>
    <time_frame>Baseline, 12 weeks, 18 weeks, 24 weeks</time_frame>
    <description>A questionnaire about goal of life, current crisis/goal, positivity, preparation and practice.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Advance Care Preference</measure>
    <time_frame>Baseline, 12 weeks, 18 weeks, 24 weeks</time_frame>
    <description>Questions about advance directive and treatment preference in case of terminal condition</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medical cost and utilization of CAM</measure>
    <time_frame>12 weeks, 24 weeks</time_frame>
    <description>Overall medical cost savings (cost effectiveness) and use of complementary and alternative medicine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>1 year survival</measure>
    <time_frame>1 year</time_frame>
    <description>1 year survival</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of CQOL</measure>
    <time_frame>Baseline, 12 weeks, 18 weeks, 24 weeks</time_frame>
    <description>A questionnaire that measures quality of life and burden for family caregivers</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in level of PHQ-9 of family caregivers</measure>
    <time_frame>Baseline, 12 weeks, 18 weeks, 24 weeks</time_frame>
    <description>9-question instrument given to caregivers in a primary care setting to screen for the presence and severity of depression.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in level of Understanding the illness of family caregivers</measure>
    <time_frame>Baseline, 12 weeks, 18 weeks, 24 weeks</time_frame>
    <description>2 questions to assess how family caregivers understand the prognosis of patients' illness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in level of Crisis Overcoming Capability(SAT-SF) of family caregivers</measure>
    <time_frame>Baseline, 12 weeks, 18 weeks, 24 weeks</time_frame>
    <description>A questionnaire about goal of life, current crisis/goal, positivity, preparation and practice of family caregivers.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Advance Care Preference of family caregivers</measure>
    <time_frame>Baseline, 12 weeks, 18 weeks, 24 weeks</time_frame>
    <description>Questions about family caregivers' preference on advance directive and treatment in case of terminal condition</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">232</enrollment>
  <condition>Advanced Cancer</condition>
  <condition>Solid Tumor</condition>
  <arm_group>
    <arm_group_label>Intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Consultation with PCT doctor every 3 weeks. Telephone coaching once a week for 3 months and once in 2 weeks for another 3 months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual palliative care can be provided if desired.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Telephone coaching</intervention_name>
    <description>Telephone coaching about overcoming the crisis is provided once a week for 3 months and once in 2 weeks for another 3 months.</description>
    <arm_group_label>Intervention group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Consultation with PCT doctor</intervention_name>
    <description>Consultation with PCT physician every 3 weeks.</description>
    <arm_group_label>Intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject 20 years and older.

          -  Subject who has an advanced cancer diagnosis (histologically or cytologically
             confirmed) due to a solid tumor

          -  Subject whose ECOG performance status is between 0 to 2.

          -  Subject with an estimated life expectancy of 12 months and less (assessed by the
             treating oncologist)

          -  Subject who volunteers

        Exclusion Criteria:

          -  Inability to speak, understand or write Korean.

          -  Medical conditions that would limit adherence to participation of the clinical
             trial(as confirmed by their referring physician; e.g. dyspnea)

          -  Suspension of all cancer treatment

          -  Palliative care consultation at any time or in palliative care
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Young Ho Yun, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eunkyo Kang, MD</last_name>
    <phone>82-2-740-8417</phone>
    <email>ekherb@naver.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jiyeon Choo</last_name>
    <phone>82-2-740-8437</phone>
    <email>greatlight1247@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam-si</city>
        <state>Gyeonggi-do</state>
        <zip>13620</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yoo Jung Kim</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gyeongsang National University Hospital</name>
      <address>
        <city>Jinju-si</city>
        <state>Gyeongsangnam-do</state>
        <zip>52727</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jung Hun Kang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chonbuk National University Hospital</name>
      <address>
        <city>Jeonju</city>
        <state>Jeollabuk-do</state>
        <zip>54907</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eun Ki Song, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Na-Ri Lee, MD, MS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chonnam National University Hwasun Hospital</name>
      <address>
        <city>Hwasun</city>
        <state>Jeollanam-do</state>
        <zip>58128</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Chungnam National University Hospital</name>
      <address>
        <city>Daejeon</city>
        <zip>35015</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hwan Jung Yun, MD, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>03722</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Asan Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>05505</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ewha Womans University Mokdong Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>07985</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ulsan University Hospital</name>
      <address>
        <city>Ulsan</city>
        <zip>44033</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Su-jin Koh, MD,PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 7, 2017</study_first_submitted>
  <study_first_submitted_qc>June 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 9, 2017</study_first_posted>
  <last_update_submitted>March 31, 2018</last_update_submitted>
  <last_update_submitted_qc>March 31, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Young Ho Yun</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Integrated Early Palliative Care</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

